TCT-69 A Randomized Comparison of The Second Generation Biodegradable Polymer Sirolimus-eluting Stent (EXCEL-II) and The First Generation EXCEL-I stent in Patients with De novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

2016 
First-in-man study has demonstrated promising feasibility, safety, and efficacy of the second generation biodegradable polymer sirolimus-eluting stent (EXCEL II), with thin cobalt-chromium struts and less sirolimus loading, in the treatment of patients with de novo coronary lesions. This study was
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map